# Efficacy of Dexmedetomidine As an Adjuvant to Bupivacaine in Pericapsular Nerve Group Block in Hip Replacement Surgeries

> **NCT06736392** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 60 (estimated)

## Conditions studied

- PENG Block

## Interventions

- **PROCEDURE:** Ultrasound guided Pericapsular Nerve Group Block
- **DRUG:** Isobaric Bupivacaine 0. 25%
- **DRUG:** 20 ml isobaric bupivacaine 0.25% and 1.5μg/kg dexmedetomidine
- **DEVICE:** the ultrasound machine with curvilinear transducer (high -frequency probe, 2.5Mhz to 7.5Mhz)
- **DEVICE:** a standard echogenic 20-22 gauge 100mm needle

## Key facts

- **NCT ID:** NCT06736392
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2026-08
- **Final completion:** 2027-03
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06736392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06736392, "Efficacy of Dexmedetomidine As an Adjuvant to Bupivacaine in Pericapsular Nerve Group Block in Hip Replacement Surgeries". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06736392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*